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Abstract: Background: Thyroid autoimmunity (TAI) is the most common autoimmune disorder in women of reproductive 
age. TAI in pregnancy is seen to rise markedly all over the world & can remain undiagnosed as it may present without 
thyroid dysfunction. It is seen to be associated with a number of feto-maternal disorders and may affect pregnancy 
outcome. The occurrence of TAI in pregnancy, in the present rural community is not known, hence this study was carried 
out to determine the occurrence of thyroid autoimmunity in pregnant women from rural area. 
Methods: A hospital based, cross-sectional, observational study was carried out among pregnant women seeking 
antenatal care at Kasturba Hospital of MGIMS, Sewagram, a rural tertiary care institute in central India. Information was 
collected about demographic variables. Family history and other determinants. Serum TSH, Free T4, and 
antithyroglobulin antibody levels were in the first trimester. Thyroid status was labelled as euthyroid, overt hypothyroid, 
subclinical hypothyroid, overt hyperthyroid and subclinical hypothyroid and correlation was done with antibody positivity 
and various determinants. 
Results: Among 250 pregnant women of first trimester, antithyroglobulin antibody was positive in 32 (12.8%) of which 22 
(68.75%) had thyroid dysfunction in the form of hypo or hyperthyroidism, and 10 (31.25 %) were euthyroid. Of 218 with 
negative antibody, 24 (11%) had thyroid dysfunction and 194 (88.99%) were euthyroid with a significant difference. 
Though TAI was present in all age groups, the numbers increased with increasing age. Among study subjects, 9.95 % 
from rural compared to 28.20 % from urban residential area had TAI indicating higher occurrence in urban population. 
TAI was observed in all socioeconomic classes but more so in middle, lower middle and lower economic class. Positive 
family history was noted in 18.75 % women with positive antibody compared to 3.71 % negative women (p value 10.62, 
chi square 0.002). More number of pregnant women with negative antibody had an average BMI compared to positive 
(77.06% vs 31.25%), more positive PW were overweight compared to negative ( 37.5% vs 18.34%) and also obese ( 
15.62% vs 0.91%) (Chi square – 26.67, p value – 0.00002). As BMI increased proportion of PW with positive antibody 
increased with a significant difference  
Conclusions: Thyroid autoimmunity was seen in 12.8% pregnant women of the rural area of present study site. A 
substantial number of women with TAI had thyroid dysfunction and some were found to be euthyroid too. Older age, 
socioeconomic status, urban residence, high BMI and positive family history were risk factors for thyroid autoimmunity. 
Screening for thyroid antibodies in high risk pregnant women and those with thyroid dysfunction is suggested.  
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INTRODUCTION 
Anti-thyroid autoantibodies (or simply anti-thyroid 
antibodies) are autoantibodies targeted against one or 
more components of thyroid, the most clinically relevant 
of which are anti-thyroperoxidase antibodies (anti-TPO 
antibodies), thyrotropin receptor antibodies (TRAbs) 
and antithyroglobulin antibodies (Anti-Tg). TRAbs are 
subdivided into activating, blocking and neutral 
antibodies, depending on their effect on the TSH 
receptor. Graves' disease and Hashimoto's thyroiditis 
are commonly associated with the presence of anti-
thyroid autoantibodies, anti-TPO antibodies with 
Hashimoto's thyroiditis & activating TRAbs are most 
commonly associated with Graves' disease [1]. Thyroid 
autoimmunity (TAI) the most common autoimmune  
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disorder in women of reproductive age, with a 
prevalence varying between 5 -15%, is 5-10 times 
more common in women than in men & can remain 
undiagnosed as it may present without TD [2]. 
Hashimoto’s thyroiditis is often defined as the simple 
presence of serum thyroid autoantibodies which, 
pathologically, correlate well with an intrathyroidal 
lymphocytic infiltrate [3]. It requires more than 75% 
compromise of thyroid function before thyroid failure is 
reflected in serum thyroid hormone levels, the disease 
existing for many years before getting diagnosed & is 
the most common cause of hypothyroidism in pregnancy 
[4]. In early pregnancy, women with thyroid antibodies 
(Abs) have higher serum TSH compared with Ab-
negative, although the mean may still fall within the 
normal range. These Ab-positive women are prone to 
develop SCH or OH during pregnancy [5] owing to 
reduced functional reserve of thyroid, which is unable to 
compensate for the increased demand of hormone in 
pregnancy [6]. Thus this study was carried out to 
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determine the occurrence of thyroid autoimmunity in 
pregnant women from rural area. 
METHODS 
Study Design and Study Site 
This hospital based, cross sectional, observational 
study was conducted in the Kasturba Hospital, placed 
in rural central India which is attached to Mahatma 
Gandhi Institute of Medical Sciences, Sewagram, 
Wardha, a tertiary level institute serving underprivi- 
leged rural masses. The hospital has separate 
maternal and Child Health wing which caters to around 
5000 deliveries per year. The antenatal and high risk 
antenatal clinic is conducted every day and serves rural 
antenatal women and offers high quality, low cost, 
diagnostic and therapeutic care. 
Study Population & Ethical Considerations 
Study participants were 250 consenting women with 
singleton pregnancy, attending antenatal clinic at 
Kasturba Hospital and were recruited in first trimester. 
Women with multiple pregnancy known thyroid 
disorders and those with diabetes mellitus were 
excluded. Ethical approval was obtained from 
institutional ethical committee, informed written consent 
was sought from participants and the research was 
conducted with no financial burden to the participants. 
Methods  
Participants were recruited in the first trimester, 
pregnancy was diagnosed with urine pregnancy test 
and confirmed with ultrasonography. Demographic 
information and relevant obstetric and clinical history 
was obtained in a pretested, validated questionnaire. 
Socioeconomic status was classified using Modified 
Prasad’s classification as upper, upper middle, middle, 
lower middle and lower using per capita income. Body 
mass index was calculated and classified according to 
WHO classification as underweight (< 18.5kg/m2), 
normal weight (18.5-24.9 kg/m2), overweight 25.0-29.9 
kg/m2 and obese (>30 kg/m2). Serum thyroid 
stimulating hormone (TSH), free thyroxine (fT4), and 
Antithyroglobulin (ATG) antibody was quantitatively 
determined using enzyme-linked immuno-assays in the 
first trimester by obtaining around 5 ml of venous blood 
sample. Trimester specific values of 0.1-2.5mIU/L were 
considered normal for TSH. Serum FT4 values 
between 0.7-1.8 mg/dl was considered normal. Thyroid 
function was classified as [7] – a) Overt hypothyroidism 
(OH) – elevated TSH levels & low free T4, defined with 
trimester specific reference ranges or TSH > 10 mIU/L 
irrespective of FT4, b) Subclinical hypothyroidism 
(SCH) - Elevated TSH, but less than 10 mIU/L and 
normal FT4, c) Overt hyperthyroidism (OHr)- Low TSH 
(Trimester Specific) with free T4 that exceeded normal 
reference range, and d) Subclinical hyperthyroidism 
(SCHr)- Low TSH, with normal free T4 within normal 
reference range. Antithyroglobulin antibody values 
>115 IU/ml were considered positive 
Statistical Analysis 
Data was entered in a spread sheet (Excel) and 
analysis was done by using descriptive statistics using 
SPSS 17.0 version. Normal distribution of the data was 
examined by Kolmogorov-Smirnov test & reported as 
arithmetic means ± SD, non-normally distributed data 
as medians (quartiles) and categorical data as 
numbers and percentages. The proportions were 
compared by chi square test & a two-level P value 
<0.05 was considered as significant. 
RESULTS 
A total of 250 participants from first trimester of 
gestation were involved in the study with a mean age of 
26.53 ± 3.67 years. Maximum were gravida two. 
Antithyroglobulin antibody was positive in 32 (12.8%) 
(Table 1). Of 32 study subjects with positive antibody 
22 (68.75%) had thyroid dysfunction in the form of hypo 
or hyperthyroidism, and 10 (31.25 %) were euthyroid. 
Of 218 with negative antibody, 24 (11%) had thyroid 
dysfunction and 194 (88.99%) were euthyroid with a 
statistically significant difference. Thyroid dysfunction, 
mostly in the form of overt or subclinical hypothyroidism 
was more commonly observed in study subjects with 
thyroid autoimmunity (TAI) (Table 2). No pregnant 
woman (PW) below 19 years of age in had TAI; 8 of 80 
(10%) between age 20-24 years; 11 of 104 (10.57%), 
between ages 25- 29 years; 11 of 60 (18.33%) 
between ages between 30 - 34 years and 2 of 5 (40 % 
who were 35 years and above had TAI. Though TAI 
was present in all age groups, the numbers increased 
with increasing age (Table 3). Among study subjects, 
21 of 211 (9.95 %) from rural as compared to 11 of 39 
(28.20 %) from urban had TAI indicating higher 
occurrence in urban population with a significant 
difference (p value < 0.001). Among study subjects, 1 
of 15 (6.66%) from upper class, 2 of 31 (6.45%) from 
upper middle; 8 of 52 (15.38 %) from middle class; 9 of 
58 (15.51%) of lower middle class and 12 of 66 (18.88 
%) of lower class had TAI indicating occurrence in all 
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classes but more so in middle, lower middle and lower 
economic class (Table 3). Of 32 PW with positive 
antibody, 6 (18.75%) had family history compared to 7 
of 218 (3.71 %) (p value 10.62, chi square 0.002 ). 
Similar proportion of PW with positive and negative 
antibody had below average BMI, however more 
number of negative PW had an average BMI compared 
to positive (77.06% vs 31.25%), more positive PW 
were overweight compared to negative (37.5% vs 
18.34%) and also obese (15.62% vs 0.91%) (chi 
square – 26.67, p value – 0.00002). As BMI increased 
proportion of PW with positive antibody increased with 
a significant difference (Table 4).  




Positive 32 12.8 Antithyroglobulin 
antibody Negative 218 87.2 
 
DISCUSSION 
Thyroid autoimmune disease, a multifactorial organ-
specific autoimmune disorder, is constantly increasing 
worldwide and is common in women of childbearing 
age. These disorders are significantly influenced by a 
variety of changes in thyroid function that take place 
during normal gestation and also by the privileged 
immune status of pregnancy [8]. TAI has been closely 
linked with thyroid function. Graves' disease and 
Hashimoto's thyroiditis are being commonly associated 
with anti-thyroid antibodies [1]. Hashimoto’s thyroiditis 
required more than 75% compromise of thyroid function 
before thyroid failure isreflected in serum thyroid 
hormone levels. The disease actually exists for many 
years before getting diagnosed & is the most common 
cause of hypothyroidism in pregnancy [4].  
In the present study, thyroid autoimmunity was 
found in 12.8 % pregnant woemn in first trimester. 
Kayode et al. in 108 pregnant women found elevated 
antithyroid antibody in 27 (25%) as against about 2% of 
Table 2:  Antithyroglobulin Antibody and Thyroid Function 
Thyroid Function 
Normal OH SCH OHr SCHr Antithyroglobulin Antibody 
n % n % n % n % n % 
Total 
Positive 10 31.25 18 56.25 3 9.37 1 3.13 0 0 32 
Negative 194 88.99 5 2.29 18 8.26 1 0.46 0 0 218 
א2-value, p value 107.32, p-value=0.0001, S 
OH-Overt Hypothyroidism, SCH- Subclinical Hypothyroidism, OHr-Overt Hyperthyroidism, SCHr- Subclinical hyperthyroidism. 
 
Table 3:  Age and Socioeconomic Status of Study Subjects of Study Subjects 
ATG Positive n=32 
Parameter Categories 
n % 
Below 19 n=19 0 0 
20-24 n=80 8 10 
25-29 n=104 11 10.57 
30-34 n=60 11 18.33 
Age in years 
35 and above n=5 2 40 
Upper n=15 1 6.66 
Upper middle n=12 2 6.65 
Middle n=52 8 15.38 
Lower Middle n=58 9 15.51 
Socioeconomic 
Status 
Lower n=66 12 18.18 
ATG- Antithyroglobulin antibody. 
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the nonpregnant women levels (P < 0.001) [9]. Various 
other studies in pregnant women from Tunisia, 
Belgium, Japan, Turkey, Spain and the United States 
reported TAI in 6.5%, 6.3%, 10%, 12%, 14.8%, and 
20% respectively [10-14]. 
In early pregnancy, women with thyroid antibodies 
have higher serum TSH compared with antibody 
negative, although the mean may still fall within the 
normal range. These women are prone to develop 
subclincal/overt hypothyroidism during pregnancy 
during pregnancy [5] owing to reduced functional 
reserve of thyroid, which is unable to compensate for 
the increased demand of hormone in pregnancy [6]. 
The present study found that 68.75 % study subjects 
with positive antibody had thyroid dysfunction in the 
form of hypo or hyperthyroidism, and 31.25 % were 
euthyroid compared with PW with negative antibody, in 
whom thyroid dysfunction was present in 11% and 
88.99% were euthyroid with a significant difference. 
Kayode et al. found that hypothyroidism was associated 
with elevated levels of TPO-Ab in 33.3% of women [9]. 
Prevalence of subclinical hypothyroidism in women 
with thyroid autoimmunity was 12.6% in the study by 
Sailakshmi et al. [15]. Prevalence of thyroid 
autoimmunity and subclinical hypothyroidism was 
18.5% in studies of Dhanwal et al. [16]. This shows that 
auto immunity is a common cause of hypothyroidism in 
pregnant women. 
Iodine defiiency and TAI may go hand in hand too. 
In Denmark, comparison of two appropriately matched 
cross-sectional groups with and without iodine 
supplementation showed a marked increase in thyroid 
antibodies with iodine supplementation probably 
secondary to the increased iodination of thyroglobulin 
which enhanced its immune-reactivity [17]. This is more 
marked in mild iodine deficient areas. 
Age can be considered as a co factor for higher 
thyroid antibody titers. Seroconversion with increasing 
age and subsequent affection of pregnancy outcome 
has been suggested [18]. In the present study it was 
seen that though TAI was seen in all age groups, the 
incidence was higher with increasing age. Few 
longitudinal studies exists in the population as regards 
to conversion to thyroid antibody positivity with age. 
Turnbridge revealed that individuals with antibody 
positivity developed increased titers as they grew older 
[19] and the original Whickham cohort, revealed that 
21% women at 55–65 years had developed TAI [20]. 
Muller et al. found that the mean age of antibody 
positive pregnant women was 32.4 +/- 3.3 years [21]. 
Bagis et al. found that mean age in antibody-positive 
was higher than antibody-negative (27.7 +/-6.2 years, 
vs. 25.9 +/- 5.2 years) [13]. Similar findings were 
reported by other researchers [22-24].  
Pregnant patients screened during the first trimester 
of pregnancy have an increased prevalence of thyroid 
autoantibodies (up to 20%) reflective of the greater 
prevalence in this age group rather than secondary to 
the pregnancy itself [25]. In fact the physiologic 
changes surrounding pregnancy include changes 
allowing an immune-tolerant environment for the non-
self fetus, and this results in a decline in 
autoantibodies. So in pregnancy, there is a marked fall 
in both TPO-Ab and Tg-Ab levels followed by an 
increase in postpartum [25]. An increase in cases of 
different autoimmune and inflammatory disorders in 
families with an index case of a given autoimmune 
disease is a consistent finding in many autoimmune 
disorders [26], and suggests a shared genetic etiology 
[27] of immune dysregulation. The present study 
observed that family history was positive in more PW 
with positive antibody compared with negative 
antibody. 
In the present study, PW with all socioeconomic 
backgrounds showed TAI however it was more 
commonly observed in middle, lower middle and lower 
socioeconomic group. The positive correlation of SES 
Table 4:  Family History and Body Mass Index of Study Subjects 
ATG Positive n=32 ATG Negative n=218 
Determinants Value 
n % n % 
Chi Square p-value 
Family History Yes 6 18.75 7 3.21 10.62 0.002 
<18.5 3 9.37 21 9.63 
18.5-24.9 10 31.25 168 77.06 
25-29.9 12 37.5 40 18.34 
BMI in kg/m2 
>30 5 15.62 2 0.91 
26.67 0.00002 
ATG- Antithyroglobulin antibody. 
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with autoimmunity is frequently attributed to biological 
etiological factors rather than differential diagnosis of 
disease in the context of access to health care 
resources. This often focuses on factors modulating the 
developing prenatal and neonatal immune system [28]. 
Increased body mass index was also shown to be a 
risk factor for TAI by some researchers. Meena et al. 
found an association between BMI and anti-TPO 
positivity in pregnant woman [29]. The majority of the 
studies showed a positive correlation between the TSH 
values and BMI [30, 31]. Pop and Nyrnes positively 
correlated TAI with BMI [30, 31]. Present study agrees 
that TAI increases with increased BMI.  
Environmental factors may induce or suppress the 
development of autoantibodies. The “Hygiene 
Hypothesis” has been supported by observations of 
increased thyroid antibodies in more affluent towns [1]. 
It is thought to be caused by multiple environmental 
factors triggering autoimmune response in genetically 
susceptible individuals, though the exact mechanisms 
linking environmental factors to thyroid autoimmunity 
are not as yet well understood. Nevertheless, there is 
increasing evidence that mainly nutritive factors and 
environmental pollution by metals and chemicals (e.g. 
organochlorines, pesticides) are the main factors in the 
present-day spread of this disease [32]. Present study 
found that PW from urban residential area were more 
prone to develop TAI. Screening for antibodies in the 
early months of pregnancy is justified to reduce 
adverse pregnancy outcomes like progressive hypothy- 
roidism during gestation with the increased risk of 
spontaneous miscarriage, postpartum thyroiditis after 
pregnancy; and the long-term risk of developing 
definitive hypothyroidism later on in life. It is important 
that all pregnant women with TAI should be monitored 
closely and jointly by obstetricians and endocrinolo- 
gists. 
CONCLUSION 
In the present geographic area of rural central India, 
thyroid autoimmnity was found in 12.8 % pregant 
women in the first trimester. A substanstial proportion 
of pregnant women with thyroid autoimmune disorder 
had thyroid dysfunction, however a number of them 
were euthyroid. Older age, socioeconomic status, 
urban residence, high BMI and positive family history 
were risk factors for thyroid autoimmunity. Screening 
women with these high risk factors in pregnancy and 
appropriately performing thyroid function tests is the 
suggested approach for cost effectivley diagnosing and 
managing pregnant women with thyroid autoimmunity 
and associated dysfunction. 
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